Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer-Reference-Cited by-同舟云学术

Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer

Published:2010-07-21 Issue:22 Volume:116 Page:5325-5335
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Tanaka Motofumi,Javle Milind,Dong Xiaoqun,Eng Cathy,Abbruzzese James L.,Li Donghui

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.25282/fullpdf

Reference45 articles.

1. Cancer statistics;Jemal;CA Cancer J Clin.,2009

2. Pancreatic cancer;Yeo;Curr Probl Cancer.,2002

3. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial;Burris;J Clin Oncol.,1997

4. Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studies;Huguet;J Clin Oncol.,2007

5. Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy;Krishnan;Cancer.,2007

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of genetic variants in the solute carrier (SLC) genes encoding drug uptake transporters on the response to anticancer chemotherapy;Cancer Drug Resistance;2024-07-18

2. An NFATc1/SMAD3/cJUN Complex Restricted to SMAD4-Deficient Pancreatic Cancer Guides Rational Therapies;Gastroenterology;2024-02

3. Large-Scale Machine Learning Analysis Reveals DNA Methylation and Gene Expression Response Signatures for Gemcitabine-Treated Pancreatic Cancer;Health Data Science;2024-01

4. Association of Single-Nucleotide Polymorphisms in Capecitabine Bioactivation Pathway with Adjuvant Therapy Safety in Colorectal Cancer Patients;Pharmaceutics;2023-10-28

5. How Cryo-EM Has Expanded Our Understanding of Membrane Transporters;Drug Metabolism and Disposition;2023-07-12